Wayne Carter, PhD

Olathe, Kansas, United States
Dr. Carter’s entire career has brought innovation into organizations centered on improving health in research and development, clinical practice, and novel technologies. He has 18 years of leadership in Fortune 500 companies and six years leading the strategic development of life sciences for the Kansas City region. He has mentored startup companies, actively worked with public and private sectors and has a proven ability to collaborate across industry and academia.

Dr. Carter's pharmaceutical experience includes 12 years at Pfizer leading a large multidisciplinary group to accelerate development decisions across Pfizer. The translational research accelerated development of oncology drugs including Tarceva and Sutent. He also served as VP Research at Colgate/Hills leading nutrigenomic research for new product development.

Dr. Carter received his BS, DVM and PhD in Immunology at Purdue University. He serves on several non-profit and for-profit boards and advisory committees.
Speaking In
11:30 AM - 11:45 AM
Wednesday, October 23
TVAX Biomedical is a privately held cancer immunotherapy company planning a Ph 2b pivotal study in…